Close Menu
Home › Hologic, Seegene to Collaborate on Multiplex MDx Test Development

Hologic, Seegene to Collaborate on Multiplex MDx Test Development

Nov 04, 2016

NEW YORK (GenomeWeb) – Seegene announced today that it has signed an agreement to develop and supply highly multiplexed real-time PCR reagents and assays for Hologic's Panther Fusion platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In PCR

  1. Inflammatix Inks BARDA Contract for up to $72M

  2. T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack

  3. Curetis Posts 17 Percent Increase in Preliminary Revenues for First Nine Months of 2019

  4. Biocept Q3 Revenues Nearly Double

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.